Training future leaders in cancer epigenetics
Cancer Epigenetics Training (CET) Program
This program is designed to help ten postdoctoral fellows learn about cancer and how genes can be changed in ways that affect the disease, so they can become independent researchers and make new discoveries in both schools and companies.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Van Andel Research Institute NIH-funded |
| Lab location | 1 site (Grand Rapids, United States) |
| Project ID | NIH-10866370 on NIH RePORTER |
What this research studies
This program aims to train postdoctoral fellows in the field of cancer epigenetics at the Van Andel Research Institute. Over the course of five years, ten fellows will be prepared to become independent researchers in both academic and industry settings. The training will cover various aspects of cancer biology, including DNA methylation, chromatin regulation, and the development of epigenetic therapies. Participants will engage in both basic and translational research projects, benefiting from mentorship by leading experts in the field.
Who could benefit from this research
Good fit: Ideal candidates for participation would be postdoctoral researchers interested in specializing in cancer epigenetics.
Not a fit: Patients who are not in the academic or research field may not receive direct benefits from this training program.
Why it matters
Potential benefit: If successful, this research could lead to advancements in understanding and treating cancers through epigenetic mechanisms.
How similar studies have performed: Similar training programs in specialized fields have shown success in developing expertise and advancing research, indicating a strong potential for this initiative.
Where this research is happening
Grand Rapids, United States
- Van Andel Research Institute — Grand Rapids, United States (Active)
Researchers
- Principal investigator: Jones, Peter a — Van Andel Research Institute
- Study coordinator: Jones, Peter a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.